ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) Announces Latest Episode of The Stock2Me Podcast featuring Two-Time Olympic Gold Medalist Abby Wambach on Behalf of Odyssey Health Inc.
July 13, 2022 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, July 13, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device
October 19, 2021 10:03 ET | Odyssey Group International
IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) --   Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion
September 22, 2021 08:39 ET | Odyssey Group International
IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference
September 09, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Approved to Start Human Trial to Treat Concussion        
September 01, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch
August 30, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment
August 06, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Completes IND-enabling Studies, Submits Investigator’s Brochure for Phase 1 Clinical Trial
August 04, 2021 09:25 ET | Odyssey Group International
IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
The Odyssey Group International Sports Advisory Board Including Three Super Bowl MVPs will Appear on “Banfield”  to Discuss Concussion Treatments
July 27, 2021 08:30 ET | Odyssey Group International
IRVINE, CA, July 27, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
July 26, 2021 08:32 ET | Odyssey Group International
IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),...